These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8542150)

  • 1. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome.
    Cochrane CG; Revak SD; Merritt TA; Heldt GP; Hallman M; Cunningham MD; Easa D; Pramanik A; Edwards DK; Alberts MS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):404-10. PubMed ID: 8542150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.
    Revak SD; Merritt TA; Cochrane CG; Heldt GP; Alberts MS; Anderson DW; Kheiter A
    Pediatr Res; 1996 Apr; 39(4 Pt 1):715-24. PubMed ID: 8848350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical properties and surface activity of surfactant-like membranes containing the cationic and hydrophobic peptide KL4.
    Sáenz A; Cañadas O; Bagatolli LA; Johnson ME; Casals C
    FEBS J; 2006 Jun; 273(11):2515-27. PubMed ID: 16704424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome.
    Merritt TA; Kheiter A; Cochrane CG
    Pediatr Res; 1995 Aug; 38(2):211-7. PubMed ID: 7478818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome.
    Cochrane CG; Revak SD; Merritt TA; Schraufstätter IU; Hoch RC; Henderson C; Andersson S; Takamori H; Oades ZG
    Pediatr Res; 1998 Nov; 44(5):705-15. PubMed ID: 9803452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
    Chen A; Shi LP; Zheng JY; Du LZ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome.
    Almlén A; Stichtenoth G; Linderholm B; Haegerstrand-Björkman M; Robertson B; Johansson J; Curstedt T
    J Appl Physiol (1985); 2008 Apr; 104(4):1101-8. PubMed ID: 18276900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats.
    Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ
    Pediatr Res; 1998 May; 43(5):666-73. PubMed ID: 9585014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome].
    Herting E; Tubman R; Halliday HL; Harms K; Speer CP; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):721-7. PubMed ID: 8413348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of surfactant treatment on gas-exchange and clinical course in near-term newborns with RDS.
    Golombek SG; Truog WE
    J Perinat Med; 2000; 28(6):436-42. PubMed ID: 11155428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
    Bae YM; Bae CW; Oh MH; Lee SH; Woo KM; Jung KB
    J Perinat Med; 2009; 37(5):561-4. PubMed ID: 19492923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits.
    Johansson J; Some M; Linderholm BM; Almlén A; Curstedt T; Robertson B
    J Appl Physiol (1985); 2003 Nov; 95(5):2055-63. PubMed ID: 12897027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome.
    Tsao PN; Wei SC; Chou HC; Su YN; Chen CY; Hsieh FJ; Hsieh WS
    Pediatr Pulmonol; 2005 May; 39(5):461-5. PubMed ID: 15786439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of exogenous surfactant during conventional and high-frequency oscillatory ventilation in preterm infants with RDS.
    Vento G; Tana M; Tirone C; Aurilia C; Lio A; Perelli S; Ricci C; Romagnoli C
    Acta Biomed; 2013; 84 Suppl 1():25-7. PubMed ID: 24049958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous surfactant administration during the transport of premature infants.
    Riek KM
    Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930
    [No Abstract]   [Full Text] [Related]  

  • 18. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.
    Escobedo MB; Gunkel JH; Kennedy KA; Shattuck KE; Sánchez PJ; Seidner S; Hensley G; Cochran CK; Moya F; Morris B; Denson S; Stribley R; Naqvi M; Lasky RE;
    J Pediatr; 2004 Jun; 144(6):804-8. PubMed ID: 15192630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Dinger J; Töpfer A; Schaller P; Schwarze R
    Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
    Hallman M; Merritt TA; Akino T; Bry K
    Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.